Thus, there is a continuum whereby GH secretion is very low and responsiveness to treatment is high in patients with severe GH deficiency, in contrast to those with severe GH resistance (Laron syndrome) where GH secretion is high and response to administered GH is very low or non-existent (5,6,7). Here, GH1 is linked to Laron syndrome.